chr9-136410684-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015160.3(PMPCA):āc.16C>Gā(p.Leu6Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000706 in 1,415,654 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015160.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PMPCA | NM_015160.3 | c.16C>G | p.Leu6Val | missense_variant | 1/13 | ENST00000371717.8 | |
PMPCA | XM_005266059.4 | c.16C>G | p.Leu6Val | missense_variant | 1/12 | ||
PMPCA | NM_001282944.2 | c.-283C>G | 5_prime_UTR_variant | 1/12 | |||
PMPCA | NM_001282946.2 | c.-283C>G | 5_prime_UTR_variant | 1/13 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PMPCA | ENST00000371717.8 | c.16C>G | p.Leu6Val | missense_variant | 1/13 | 1 | NM_015160.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000165 AC: 2AN: 121288Hom.: 0 AF XY: 0.0000146 AC XY: 1AN XY: 68352
GnomAD4 exome AF: 0.00000554 AC: 7AN: 1263326Hom.: 0 Cov.: 30 AF XY: 0.00000483 AC XY: 3AN XY: 620538
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74482
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 26, 2023 | The c.16C>G (p.L6V) alteration is located in exon 1 (coding exon 1) of the PMPCA gene. This alteration results from a C to G substitution at nucleotide position 16, causing the leucine (L) at amino acid position 6 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at